Keywords: AMD; age-related macular degeneration; ANCHOR; Anti-vascular endothelial growth factor (VEGF) Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization (CNV) in Age-related Macular Degeneration; BRAVO; Ranibizumab for the Treatment
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 0.5q4; 0.5 mg intravitreal aflibercept injection every 4 weeks; 2q4; 2 mg intravitreal aflibercept injection every 4 weeks; 2q8; 2 mg intravitreal aflibercept injection every 8 weeks after 3 initial monthly injections; ANCHOR; Anti-VEGF Antibody for the T
Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
Keywords: AMD; age-related macular degeneration; ANCHOR; Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in AMD; BCVA; best-corrected visual acuity; CATT; Comparison of Age-Related Macular Degeneration Treatments Trials; C
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration
Keywords: EMR; electronic medical record; nAMD; neovascular age-related macular degeneration; PRN; pro re nata; VIEW; VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD;
Improvement in Vision-Related Function with Intravitreal Aflibercept
Keywords: AMD; age-related macular degeneration; ETDRS; Early Treatment Diabetic Retinopathy; NEI VFQ-25; 25-item National Eye Institute Visual Function Questionnaire; QoL; quality of life; VA; visual acuity; VEGF; vascular endothelial growth factor; VIEW; VEGF Tra
Pigment Epithelial Detachment Followed by Retinal Cystoid Degeneration Leads to Vision Loss in Treatment of Neovascular Age-Related Macular Degeneration
Keywords: AMD; age-related macular degeneration; CATT; Comparison of AMD Treatment Trials; CNV; choroidal neovascularization; CRT; central retinal thickness; EMA; European Medicines Agency; ETDRS; Early Treatment Diabetic Retinopathy Study; FDA; Food and Drug Admin